Search the web
Welcome, Guest
[Sign Out, My Account]
EDGAR_Online

Quotes & Info
Enter Symbol(s):
e.g. YHOO, ^DJI
Symbol Lookup | Financial Search
CRMD > SEC Filings for CRMD > Form 8-K on 30-Jul-2013All Recent SEC Filings

Show all filings for CORMEDIX INC.

Form 8-K for CORMEDIX INC.


30-Jul-2013

Change in Directors or Principal Officers, Submission of Matters to a Vote of Secur


Item 5.02. Departure of Directors or Principal Officers; Election of Directors; Appointment of Principal Officers.

(e) At the 2013 annual meeting of stockholders of CorMedix Inc. (the "Company"), stockholders approved the CorMedix Inc. 2013 Stock Incentive Plan (the "Plan"). A total of 5,000,000 shares of Company common stock have been reserved for issuance under the Plan to employees, directors and consultants of the Company. Unless sooner terminated, the Plan will terminate on March 20, 2023, and no further awards would be made under the Plan after that date. You can find a summary of the principal features of the Plan in the definitive proxy statement for the Company's 2013 annual meeting of stockholders, as filed with the U.S. Securities and Exchange Commission on June 20, 2013, under the heading "Proposal No. 3 - Approval of the CorMedix Inc. 2013 Stock Incentive Plan." The description of the Plan is qualified in its entirety by reference to the full and complete text of the Plan, which will be filed as an exhibit to the Company's Quarterly Report on Form 10-Q for the quarter ended June 30, 2013.



Item 5.07. Submission of Matters to a Vote of Security Holders.

The Company's 2013 annual meeting of stockholders was held on July 30, 2013. At the meeting, stockholders elected the following five members to the Company's Board of Directors for a term expiring at the annual meeting of stockholders in 2014, based on the following votes:

Member For Withheld Broker Non-Votes Richard M. Cohen 4,683,215 921,255 3,467,618 Matthew Duffy 5,602,820 1,650 3,467,618 Gary A. Gelbfish, M.D. 5,602,820 1,650 3,467,618 Steven Lefkowitz 5,602,820 1,650 3,467,618 Antony E. Pfaffle, M.D. 5,562,284 42,186 3,467,618

Company stockholders also voted on the approval of the issuance of shares of the Company's common stock upon conversion of the Company's 8% senior secured convertible notes and related warrants if the conversion or exercise thereof requires the issuance of shares in excess of the New York Stock Exchange limits for share issuances without stockholder approval. The vote on the resolution was approved with 5,529,241 shares for, 42,247 shares against, 32,982 shares abstaining and 3,467,618 broker non-votes.

Company stockholders also voted on the approval of the CorMedix Inc. 2013 Stock Incentive Plan. The vote on the resolution was approved with 5,463,579 shares for, 103,641 shares against, 37,250 shares abstaining and 3,467,618 broker non-votes.

At the meeting, stockholders also ratified the appointment of CohnReznick LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2013. The vote for such ratification was 8,990,838 shares for, 1,477 shares against and 79,773 shares abstaining.


  Add CRMD to Portfolio     Set Alert         Email to a Friend  
Get SEC Filings for Another Symbol: Symbol Lookup
Quotes & Info for CRMD - All Recent SEC Filings
Copyright © 2014 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
SEC Filing data and information provided by EDGAR Online, Inc. (1-800-416-6651). All information provided "as is" for informational purposes only, not intended for trading purposes or advice. Neither Yahoo! nor any of independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. By accessing the Yahoo! site, you agree not to redistribute the information found therein.